iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma

Area of Science:

• Oncology
• Proteomics
• Biochemistry

Background:

• Esophageal squamous cell carcinoma (ESCC) is a prevalent and aggressive cancer.
• Understanding protein expression changes is crucial for diagnosing and treating ESCC.
• Previous research has limited insights into specific protein alterations in ESCC.

Purpose of the Study:

• To identify differentially regulated proteins in ESCC tumor tissues compared to adjacent normal tissues.
• To utilize quantitative proteomics techniques for comprehensive protein profiling.
• To discover novel protein biomarkers associated with ESCC development.

Main Methods:

• Isobaric tag for relative and absolute quantification (iTRAQ) technique was employed for protein quantification.
• Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used for protein identification.
• Comparative proteomic analysis was performed on three pairs of ESCC tumor and adjacent normal tissues.

Main Results:

• 72 proteins were significantly upregulated and 57 proteins were significantly downregulated across all three samples.
• A total of 431 proteins showed differential regulation in at least two biological samples.
• Specific proteins like prolyl 4-hydroxylase subunits, calponin-2, and prolyl 3-hydroxylase1 were identified as potentially significant in ESCC.

Conclusions:

• Quantitative proteomics is a powerful tool for identifying differentially expressed proteins in cancer.
• The identified proteins represent potential biomarkers for ESCC diagnosis and therapeutic targeting.
• Further validation studies are warranted for the discovered proteins in larger patient cohorts.